Germany's Stada is on the look out for consumer health acquisitions globally that can help it reach its ambition to grow faster than the market in 2019. The firm's new private-equity owners are backing CEO Peter Goldschmidt's plan to take the Branded Products division to the next level.
“Rapid expansion” of its consumer health-focused Branded Products division through acquisitions is a core focus for Stada Arzneimittel AG in 2019 as its private-equity owners look to ramp up sales and earnings at the unit.
Stada is seeking “value-added acquisitions” to grow Branded Products. “These could be pharmaceutical products or entire companies, as long as...
In a major milestone for the EU’s pricing and reimbursement landscape, the European Commission has published the first ever, much anticipated, joint clinical assessment report.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Weak demand for virus-blocking nasal sprays since the pandemic has left Austrian biotech Marinomed with mounting debts. The company has applied for restructuring proceedings with an Austrian court in an attempt to secure its future.
Perrigo aims its new SolpaOne high-strength paracetamol effervescent at UK pharmacists, who now have expanded powers as part of the UK government's Pharmacy First initiative.
Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.
